Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, International, Multicenter Registry of Patients Undergoing Segmental Mandibular Defects Reconstruction (SMDR) After Mandibular Resection for Tumors and Drugs-induced Osteonecrosis

NCT04098146 is registered in ClinicalTrials.gov with AO Innovation Translation Center as lead sponsor.

NCT NCT04098146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04098146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, International, Multicenter Registry of Patients Undergoing Segmental Mandibular Defects Reconstruction (SMDR) After Mandibular Resection for Tumors and Drugs-induced Osteonecrosis
Lead sponsor
AO Innovation Translation Center
Phase
Observational
Overall status
Recruiting
Start date
September 12, 2022
Completion date
December 31, 2030
Enrollment
300 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

mandibular reconstruction, segmental mandibular defects